Dr. Miyamoto currently holds four academic appointments at Temple University as Chief in Medical Oncology, including Acting Service Chief in Medical Oncology, Medical Director at the Cancer Center, Professor and Chairperson of the Hospital, and Professor in Radiation Oncology. He is a staff radiation oncologist at the Temple University Hospital and held this position previously at Hahnemann University Hospital and West Michigan Cancer Center. Dr. Miyamoto has been a reviewer of numerous journals including American Journal of Clinical Oncology and on the editorial board of Radiation Oncology Investigations. He is a member of several professional organizations at the local, regional, and national levels. He is involved in many committees at Temple University and Hahnemann University and their affiliated hospitals. Dr. Miyamoto has published over thirty peer-reviewed articles in various medical journals. In addition, he has written various other literatures including books, chapters, and abstracts in Radiation Oncology and holds two patents. He has given over a hundred presentations around the world regarding different aspects of radiation oncology and patients care. He is an executive board member for the Philadelphia County Medical Society, a founding member of the Association Ibero Latinoamericana de Terapia Radiante Oncologica, a founding board member of the Robert Zaloga Brain Tumor Foundation, and on the advisory board of the Prevent Cancer Foundation. Dr. Miyamoto is involved in cancer research and has research grants from U.S. Department of Defense and the Robert Zaloga Brain Tumor Foundation. He received his degree of B.S. in Biology from Muhlenberg College in Allentown, PA and M.D. degree from Universidad de Navarra in Spain. He completed his residency in radiation oncology from Hahnemann University Hospital in Philadelphia, PA. He currently holds a M.D. license in Pennsylvania since 1988. Dr. Miyamoto has won the Ôø_Physicians Recognition AwardÔø_ from the American Medical Association in 1994.
General External Beam Radiation
3-D Conformal Radiotherapy